Lauren E. Black

Statistics

Publications

Citations

1.3K

H-Index

Active since

1993

Affiliations

Charles River Laboratories (United States)(Current)

United States Food and Drug Administration

Boston Children's Hospital

Charles River Laboratories (Netherlands)

National Centre for the Replacement Refinement and Reduction of Animals in Research

Lauren E. Black is an author at Charles River Laboratories (United States) specializing in pharmacology, toxicology, and preclinical safety evaluation.

ORCID

Publications per year

1993–2023

Publications

Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease

Jin‐Kuk Kim, Chunguang Hu, Christelle Moufawad El Achkar et al. · New England Journal of Medicine · 2019 · 805 citations · Full text

Life Sciences, Molecular Medicine, Neurology +17

Pharmaceutical toxicology: Designing studies to reduce animal use, while maximizing human translation

Kathryn Chapman, Henry H. Holzgrefe, Lauren E. Black et al. · Regulatory Toxicology and Pharmacology · 2013 · 135 citations · Full text

Pharmacy, Pharmacology, Toxicology +17

An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the <i>UBE3A-AS</i> transcript

Scott V. Dindot, Sarah Christian, William J. Murphy et al. · Science Translational Medicine · 2023 · 93 citations

Life Sciences, Genetics, Molecular Genetics +13

The design of chronic toxicology studies of monoclonal antibodies: Implications for the reduction in use of non-human primates

Kathryn Chapman, Laura Andrews, Jeffrey J. Bajramović et al. · Regulatory Toxicology and Pharmacology · 2011 · 67 citations

Pharmacy, Pharmacology, Toxicology +9

Regulatory Considerations for Oligonucleotide Drugs: Updated Recommendations for Pharmacology and Toxicology Studies

Lauren E. Black, James G. Farrelly, JOY A. CAVAGNARO et al. · Antisense Research and Development · 1994 · 62 citations

Medicine, Pharmacology, Toxicology +17

1–5 of 9